NO941884D0 - 1,3-substituerte cykloalkener og cykloalkaner som sentralnervesystem-midler - Google Patents
1,3-substituerte cykloalkener og cykloalkaner som sentralnervesystem-midlerInfo
- Publication number
- NO941884D0 NO941884D0 NO941884A NO941884A NO941884D0 NO 941884 D0 NO941884 D0 NO 941884D0 NO 941884 A NO941884 A NO 941884A NO 941884 A NO941884 A NO 941884A NO 941884 D0 NO941884 D0 NO 941884D0
- Authority
- NO
- Norway
- Prior art keywords
- nervous system
- central nervous
- cycloalkanes
- system agents
- substituted cycloalkenes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
- C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing alicyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/08—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing alicyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/08—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing alicyclic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychology (AREA)
- Reproductive Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Manufacture Of Tobacco Products (AREA)
- Luminescent Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US79520791A | 1991-11-20 | 1991-11-20 | |
US07/957,277 US5314896A (en) | 1991-11-20 | 1992-10-15 | 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents |
PCT/US1992/009583 WO1993010092A1 (en) | 1991-11-20 | 1992-11-05 | 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents |
Publications (4)
Publication Number | Publication Date |
---|---|
NO941884D0 true NO941884D0 (no) | 1994-05-19 |
NO941884L NO941884L (no) | 1994-05-19 |
NO180632B NO180632B (no) | 1997-02-10 |
NO180632C NO180632C (no) | 1997-05-21 |
Family
ID=27121601
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO941884A NO180632C (no) | 1991-11-20 | 1994-05-19 | 1,3-substituerte cykloalkener og cykloalkaner som sentralnervesystem-midler |
Country Status (20)
Country | Link |
---|---|
US (2) | US5314896A (no) |
EP (2) | EP0545095A1 (no) |
JP (1) | JP3193718B2 (no) |
KR (1) | KR100234600B1 (no) |
AT (1) | ATE206398T1 (no) |
AU (1) | AU664872B2 (no) |
CA (1) | CA2122911C (no) |
CZ (1) | CZ284181B6 (no) |
DE (1) | DE69232099T2 (no) |
DK (1) | DK0613465T3 (no) |
ES (1) | ES2165360T3 (no) |
FI (2) | FI106259B (no) |
HU (1) | HU218935B (no) |
NO (1) | NO180632C (no) |
NZ (1) | NZ245174A (no) |
PT (1) | PT613465E (no) |
RU (1) | RU2116297C1 (no) |
SG (1) | SG46641A1 (no) |
SK (1) | SK280812B6 (no) |
WO (1) | WO1993010092A1 (no) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5401692A (en) * | 1993-06-15 | 1995-03-28 | Texas Instruments Incorporated | Method for minimizing particle generation on a wafer surface during high pressure oxidation of silicon |
US5468767A (en) * | 1994-01-06 | 1995-11-21 | Bristol-Myers Squibb Company | Antidepressant 3-(aminocycloalkenyl)-indole-5-nitrile derivatives |
US5468768A (en) * | 1994-01-06 | 1995-11-21 | Bristol-Myers Squibb Company | Antimigraine derivatives of indolylcycloalkanylamines |
US5710277A (en) * | 1994-09-12 | 1998-01-20 | Warner-Lambert Company | Process for R (+) 1,2,3,6-tetrahydro-4-phenyl-1- (3-phenyl-3-cyclohexen-1-yl)methyl!pyridine, a central nervous system agent |
US5773616A (en) * | 1995-02-15 | 1998-06-30 | Neurogen Corporation | Certain bridged 4-phenyl-2-aminomethylimidazoles; new dopamine receptor subtype specific ligands |
WO1996025411A1 (en) * | 1995-02-15 | 1996-08-22 | Neurogen Corporation | Certain bridged 4-phenyl-2-aminomethylimidazoles; new dopamine receptor subtype specific ligands |
JP3884477B2 (ja) * | 1995-03-22 | 2007-02-21 | 大正製薬株式会社 | チアゾール誘導体 |
US6245768B1 (en) | 1995-06-05 | 2001-06-12 | Neurogen Corporation | 1-(N′-(arylalkylaminoalkyl)) aminoisoindoles; a new class of dopamine receptor subtype specific ligands |
US5656632A (en) * | 1995-06-05 | 1997-08-12 | Neurogen Corporation | 1-(N'-(arylalkylaminoalkyl)) aminoisoindoles; dopamine receptor subtype specific ligands |
US5602168A (en) * | 1995-07-10 | 1997-02-11 | Neurogen Corporation | 1-(N'-(arylalkylaminoalkyl)) aminoisoindoles; dopamine receptor subtype specific ligands |
US5633724A (en) * | 1995-08-29 | 1997-05-27 | Hewlett-Packard Company | Evanescent scanning of biochemical array |
GB9523462D0 (en) * | 1995-11-16 | 1996-01-17 | Merck Sharp & Dohme | Therapeutic agents |
WO1999051576A1 (en) * | 1998-04-08 | 1999-10-14 | American Home Products Corporation | N-aryloxyethylamine derivatives for the treatment of depression |
US6200994B1 (en) | 1999-01-07 | 2001-03-13 | American Home Products Corp | 1,4-Disubstituted cyclohexane derivatives for the treatment of depression |
US6313126B1 (en) | 1999-01-07 | 2001-11-06 | American Home Products Corp | Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression |
DE60000405T2 (de) * | 1999-01-07 | 2003-08-07 | Wyeth, Madison | 1,4-disubstitutierte cyclohexanderivate zur behandlung von depression |
US6245780B1 (en) * | 1999-04-22 | 2001-06-12 | American Home Products Corp | Tetrahydroisoquinolinyl-indole derivatives for the treatment of depression |
IL148218A0 (en) | 1999-08-23 | 2002-09-12 | Solvay Pharm Bv | New phenylpiperazines |
US6780305B2 (en) * | 2001-02-20 | 2004-08-24 | Fuji Photo Film Co., Ltd. | Method for producing support for planographic printing plate, support for planographic printing plate, and planographic printing plate precursor |
AR032712A1 (es) * | 2001-02-21 | 2003-11-19 | Solvay Pharm Bv | Un mesilato de derivados de fenilpiperazina y composiciones farmaceuticas que lo contienen |
US20040197284A1 (en) | 2003-04-04 | 2004-10-07 | Frederic Auguste | Cosmetic composition comprising a volatile fatty phase |
UY28538A1 (es) | 2003-09-26 | 2005-04-29 | Vertex Pharma | Derivados de fenil-piperazina como moduladores de receptores muscarínicos |
US8217027B2 (en) | 2006-12-21 | 2012-07-10 | Abbott Laboratories | Sphingosine-1-phosphate receptor agonist and antagonist compounds |
WO2008079380A1 (en) | 2006-12-21 | 2008-07-03 | Abbott Laboratories | Process for the preparation and isolation of the individual stereoisomers of 1-amino, 3-substituted phenylcyclopentane carboxylates |
CL2007003784A1 (es) * | 2006-12-21 | 2008-06-27 | Abbott Lab | Compuestos derivados de 1-amino-3-fenilciclopentano, que son agonistas o antagonistas de uno o mas receptores de la familia s1p; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar la esclerosis multiple, artritis reumato |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4597921A (en) * | 1984-07-26 | 1986-07-01 | Northern Telecom Limited | Provision of plastic insulation upon an electrical conductor |
US4954502A (en) * | 1988-06-10 | 1990-09-04 | Bristol-Myers Squibb Company | 1-indolyalkyl-4-(substituted-pyridinyl)piperazines |
US4957921A (en) * | 1989-12-06 | 1990-09-18 | Warner-Lambert Company | Substituted cyclohexanols as central nervous system agents |
US4975445A (en) * | 1989-12-06 | 1990-12-04 | Warner-Lambert Company | Substituted cyclohexenes as central nervous system agents |
US5124332A (en) * | 1991-01-28 | 1992-06-23 | Warner-Lambert Company | Substituted indoles as central nervous system agents |
-
1992
- 1992-10-15 US US07/957,277 patent/US5314896A/en not_active Expired - Fee Related
- 1992-11-05 CA CA002122911A patent/CA2122911C/en not_active Expired - Fee Related
- 1992-11-05 HU HU9401468A patent/HU218935B/hu not_active IP Right Cessation
- 1992-11-05 PT PT92925105T patent/PT613465E/pt unknown
- 1992-11-05 KR KR1019940701684A patent/KR100234600B1/ko not_active IP Right Cessation
- 1992-11-05 DK DK92925105T patent/DK0613465T3/da active
- 1992-11-05 WO PCT/US1992/009583 patent/WO1993010092A1/en active IP Right Grant
- 1992-11-05 CZ CZ941161A patent/CZ284181B6/cs not_active IP Right Cessation
- 1992-11-05 JP JP50933393A patent/JP3193718B2/ja not_active Expired - Fee Related
- 1992-11-05 SK SK569-94A patent/SK280812B6/sk unknown
- 1992-11-05 EP EP92118998A patent/EP0545095A1/en active Pending
- 1992-11-05 AU AU31291/93A patent/AU664872B2/en not_active Ceased
- 1992-11-05 DE DE69232099T patent/DE69232099T2/de not_active Expired - Fee Related
- 1992-11-05 ES ES92925105T patent/ES2165360T3/es not_active Expired - Lifetime
- 1992-11-05 SG SG1996006952A patent/SG46641A1/en unknown
- 1992-11-05 EP EP92925105A patent/EP0613465B1/en not_active Expired - Lifetime
- 1992-11-05 AT AT92925105T patent/ATE206398T1/de not_active IP Right Cessation
- 1992-11-05 RU RU94028888/04A patent/RU2116297C1/ru not_active IP Right Cessation
- 1992-11-18 NZ NZ245174A patent/NZ245174A/en unknown
-
1994
- 1994-02-04 US US08/192,238 patent/US5409931A/en not_active Expired - Fee Related
- 1994-05-18 FI FI942310A patent/FI106259B/fi not_active IP Right Cessation
- 1994-05-19 NO NO941884A patent/NO180632C/no not_active IP Right Cessation
-
1998
- 1998-03-02 FI FI980471A patent/FI107383B/fi not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO180632C (no) | 1,3-substituerte cykloalkener og cykloalkaner som sentralnervesystem-midler | |
DK0431580T3 (da) | Substituerede cyclohexanoler med virkning på centralnervesystemet | |
DK0491664T3 (da) | Indolderivater som serotonin-antagonister | |
CA2094702A1 (en) | Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents | |
GR3019490T3 (en) | Substituted piperazines as central nervous system agents | |
DK0431579T3 (da) | Substituerede cyclohexener som midler med virkning på centralnervesystemet | |
PT889044E (pt) | Derivados do 5-(heteroaril)alquil-3-oxo-pirido-(1,2-a)benzimidazole-4-carboxamida (pbi) uteis no tratamento de perturbacoes do sistema nervoso central |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |